ICM
CEROW

Ionic Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Ionic Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80,300
Closed -$5.48K – 189
2024
Q1 		$5.48K Buy
+80,300
New +$4.88K ﹤0.01% 136

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Ionic Capital Management's CEROW Position: Q2 2024 in Review

Ionic Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q2 2024, closing a stake of 80,300 shares — an estimated $5.48K sold.

Ionic Capital Management first reported a position in CEROW in Q1 2024 and held it in 1 quarter. The position peaked at $5.48K in Q1 2024. 34 funds tracked by Wall St. Rank hold CEROW as of Q2 2024.

  • Ionic Capital Management reported no remaining CERo Therapeutics Warrants position as of Q2 2024 after selling out during the quarter.
  • Ionic Capital Management sold 80,300 CERo Therapeutics Warrants shares in Q2 2024, an estimated $5.48K.
  • Ionic Capital Management first reported a position in CERo Therapeutics Warrants in Q1 2024 and held it in 1 quarter.
  • Ionic Capital Management's CERo Therapeutics Warrants position peaked at $5.48K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2024.

Based on Ionic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.